The University of Chicago Header Logo

Connection

Richard A. Larson to Myeloablative Agonists

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Myeloablative Agonists.
Richard A. Larson
Connection Strength
0.050
Myeloablative Agonists
  1. Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103). Cancer Chemother Pharmacol. 2014 Nov; 74(5):927-38.
    View in: PubMed
    Score: 0.030
  2. Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008 Nov; 14(11):1209-16.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.